Globus Medical, Inc.
Globus Medical, Inc. (GMED) Stock Overview
Explore Globus Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.5B
P/E Ratio
28.52
EPS (TTM)
$3.09
ROE
0.10%
GMED Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Globus Medical, Inc. (GMED) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.09.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.52 and a market capitalization of 12.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.